Prenetics Global Limited

NasdaqGM:PRE Stock Report

Market Cap: US$105.4m

Prenetics Global Management

Management criteria checks 1/4

Prenetics Global's CEO is Danny Yeung, appointed in Jan 2014, has a tenure of 11.33 years. directly owns 12.13% of the company’s shares, worth $12.79M. The average tenure of the management team and the board of directors is 4.8 years and 2.2 years respectively.

Key information

Danny Yeung

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure11.3yrs
CEO ownership12.1%
Management average tenure4.8yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 50% Share Price Bounce

May 11
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 50% Share Price Bounce

What You Can Learn From Prenetics Global Limited's (NASDAQ:PRE) P/S After Its 27% Share Price Crash

Mar 27
What You Can Learn From Prenetics Global Limited's (NASDAQ:PRE) P/S After Its 27% Share Price Crash

Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 32% Share Price Bounce

Dec 16
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 32% Share Price Bounce

Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors

Oct 12
Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors

Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump

May 29
Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump

Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues

Apr 08
Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues

Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Jan 07
Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M

Sep 09

CEO

Danny Yeung (45 yo)

11.3yrs
Tenure

Mr. Sheng Wu Yeung, also known as Danny, serves as Co-Founder, Chief Executive Officer and Director at Prenetics Global Limited since 2014 and serves as its Chairman. He served as Founding Partner at SXE V...

Leadership Team

NamePositionTenureCompensationOwnership
Sheng Wu Yeung
Co-Founder11.3yrsno data12.13%
$ 12.8m
Chi Hung Tzang
Co-Founder & Chief Scientific Officer11.3yrsno data4.12%
$ 4.3m
Hoi Chun Lo
Chief Financial Officer7.3yrsno data1.25%
$ 1.3m
Samantha Kwok
Chief of Staff to Group CEO & Vice President of People & Operations2.3yrsno datano data
Senthil Kumar Sundaram
Chief Clinical Officerno datano datano data
Joel Neoh
Chief Consumer Officer1.9yrsno datano data
David Vanderveen
Director & President of Americasless than a yearno datano data
4.8yrs
Average Tenure
47yo
Average Age

Experienced Management: PRE's management team is considered experienced (4.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sheng Wu Yeung
Co-Founder11.3yrsno data12.13%
$ 12.8m
David Vanderveen
Director & President of Americasless than a yearno datano data
Pasi Antero Janne
Member of Scientific Advisory Board2.2yrsno datano data
Kathryn Henry
Independent Directorless than a yearno datano data
Wing Kwan Chiu
Independent Directorno datano datano data
David L. Katz
Member of Scientific & Medical Advisory Boardno datano datano data
Shu Kam Mok
Chairman of Scientific Advisory Board2.2yrsno datano data
Yin Pan Cheng
Independent Directorno datano datano data
Suzanne Devkota
Member of Scientific & Medical Advisory Boardno datano datano data
Pan-Chyr Yang
Member of Scientific Advisory Board2.2yrsno datano data
James L. Green
Member of Scientific Advisory Board1.3yrsno datano data
Dawn Mussallem
Member of Scientific & Medical Advisory Boardno datano datano data
2.2yrs
Average Tenure
55yo
Average Age

Experienced Board: PRE's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/21 15:35
End of Day Share Price 2025/05/21 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Prenetics Global Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ross OsbornCantor Fitzgerald & Co.